Related references
Note: Only part of the references are listed.Identification and characterization of a novel ISG15-ubiquitin mixed chain and its role in regulating protein homeostasis
Jun-Bao Fan et al.
SCIENTIFIC REPORTS (2015)
Type I interferons have opposing effects during the emergence and recovery phases of colitis
Isabella Rauch et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
ISGylation governs the oncogenic function of Ki-Ras in breast cancer
J. Burks et al.
ONCOGENE (2014)
ARF and p53 Coordinate Tumor Suppression of an Oncogenic IFN-β-STAT1-ISG15 Signaling Axis
Jason T. Forys et al.
CELL REPORTS (2014)
Cytokines in inflammatory bowel disease
Markus F. Neurath
NATURE REVIEWS IMMUNOLOGY (2014)
Replication Study of Ulcerative Colitis Risk Loci in a Lithuanian-Latvian Case-Control Sample
Jurgita Skieceviciene et al.
INFLAMMATORY BOWEL DISEASES (2013)
The Antiviral Activities of ISG15
David J. Morales et al.
JOURNAL OF MOLECULAR BIOLOGY (2013)
Gene Expression Classification of Colon Cancer into Molecular Subtypes: Characterization, Validation, and Prognostic Value
Laetitia Marisa et al.
PLOS MEDICINE (2013)
Cross-Seeding of Misfolded Proteins: Implications for Etiology and Pathogenesis of Protein Misfolding Diseases
Rodrigo Morales et al.
PLOS PATHOGENS (2013)
ISG15: leading a double life as a secreted molecule
Dusan Bogunovic et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2013)
Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients
Balazs Gyoerffy et al.
ENDOCRINE-RELATED CANCER (2012)
ISG15 disrupts cytoskeletal architecture and promotes motility in human breast cancer cells
Shyamal D. Desai et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2012)
Comprehensive molecular characterization of human colon and rectal cancer
Donna M. Muzny et al.
NATURE (2012)
Dextran Sodium Sulfate (DSS) Induces Colitis in Mice by Forming Nano-Lipocomplexes with Medium-Chain-Length Fatty Acids in the Colon
Hamed Laroui et al.
PLOS ONE (2012)
Immunomodulatory functions of type I interferons
Jose M. Gonzalez-Navajas et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Recent Insights Into the Genetics of Inflammatory Bowel Disease
Judy H. Cho et al.
GASTROENTEROLOGY (2011)
Interferon-Stimulated Gene 15 and the Protein ISGylation System
Dongxian Zhang et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2011)
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47
Carl A. Anderson et al.
NATURE GENETICS (2011)
A Novel Role for ATM in Regulating Proteasome-Mediated Protein Degradation through Suppression of the ISG15 Conjugation Pathway
Laurence M. Wood et al.
PLOS ONE (2011)
Immunoproteasomes Preserve Protein Homeostasis upon Interferon-Induced Oxidative Stress
Ulrike Seifert et al.
CELL (2010)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
Inflammation and Colon Cancer
Janos Terzic et al.
GASTROENTEROLOGY (2010)
Mutated KRAS Results in Overexpression of DUSP4, a MAP-Kinase Phosphatase, and SMYD3, a Histone Methyltransferase, in Rectal Carcinomas
Jochen Gaedcke et al.
GENES CHROMOSOMES & CANCER (2010)
Interferon beta-1a for the maintenance of remission in patients with Crohn's disease: results of a phase II dose-finding study
Claudia Pena Rossi et al.
BMC GASTROENTEROLOGY (2009)
Alteration of tumor spectrum by ISGylation in p53-deficient mice
Xiaoyan Yin et al.
CANCER BIOLOGY & THERAPY (2009)
Deficiency of a potential 3p21.3 tumor suppressor gene UBE1L (UBA7) does not accelerate lung cancer development in K-rasLA2 mice
Xiaoyan Yin et al.
LUNG CANCER (2009)
Expression, regulation and function of the ISGylation system in prostate cancer
A. Kiessling et al.
ONCOGENE (2009)
Clinical trial:: a multicentre, randomized, double-blind, placebo-controlled, dose-finding, phase II study of subcutaneous interferon-β-1a in moderately active ulcerative colitis
C. Pena-Rossi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
ISG15 inhibits Nedd4 ubiquitin E3 activity and enhances the innate antiviral response
Oxana A. Malakhova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
Interferon-inducible antiviral effectors
Anthony J. Sadler et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Whole genome analysis for liver metastasis gene signatures in colorectal cancer
Dong Hyuk Ki et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Unravelling the pathogenesis of inflammatory bowel disease
R. J. Xavier et al.
NATURE (2007)
Development of ulcerative colitis in a patient with multiple sclerosis following treatment with interferonβ 1a
Eckart Schott et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
ISG15 modification of the eIF4E cognate 4EHP enhances cap structure-binding activity of 4EHP
Fumihiko Okumura et al.
GENES & DEVELOPMENT (2007)
An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression
Clemens Neufert et al.
NATURE PROTOCOLS (2007)
ATP binding and ATP hydrolysis play distinct roles in the function of 26S proteasome
Chang-Wei Liu et al.
MOLECULAR CELL (2006)
HERC5 is an IFN-induced HECT-type E3 protein ligase that mediates type I IFN-induced ISGylation of protein targets
Joyce Jing Yi Wong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Herc5, an interferon-induced HECT E3 enzyme, is required for conjugation of ISG15 in human cells
A Dastur et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The interferon-inducible ubiquitin-protein isopeptide ligase (E3) EFP also functions as an ISG15 E3 ligase
WG Zou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Elevated expression of IS615 in tumor cells interferes with the ubiquitin/26S proteasome pathway
SD Desai et al.
CANCER RESEARCH (2006)
Toll-like receptor 9-induced type IIFN protects mice from experimental colitis
K Katakura et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Binding of polyubiquitin chains to ubiquitin-associated (UBA) domains of HHR23A
S Raasi et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
Interferon-inducible ubiquitin E2, Ubc8, is a conjugating enzyme for protein ISGylation
KI Kim et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
The UbcH8 ubiquitin E2 enzyme is also the E2 enzyme for ISG15, an IFN-α/β-induced ubiquitin-like protein
C Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Protein ISGylation modulates the JAK-STAT signaling pathway
OA Malakhova et al.
GENES & DEVELOPMENT (2003)
Proteasome inhibitors stimulate activator protein-1 pathway via reactive oxygen species production
HM Wu et al.
FEBS LETTERS (2002)
Lipopolysaccharide-mediated reactive oxygen species and signal transduction in the regulation of interleukin-1 gene expression
HY Hsu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
UBP43 (USP18) specifically removes ISG15 from conjugated proteins
MP Malakhov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein
WM Yuan et al.
EMBO JOURNAL (2001)
Share Paper
